Parkinson’s Disease Research News

Share on FacebookTweet about this on Twitter

Newsfeed:

  • Parkinson’s drugs may lead to compulsive behavior
    A new study finds that, with time, half of those who take dopamine agonists develop compulsive shopping, eating, gambling, or sexual behaviors. ... read more
    Source: Medical News DailyPublished on 2018-06-21
  • Half of Those on Parkinson’s Drugs Develop Impulse Control Problems
    A new study reports Parkinson's patients who take dopamine agonists are more likely to develop impulse control disorders. ... read more
    Source: Neuro Science NewsPublished on 2018-06-20By Neuroscience News
  • Half of those on Parkinson’s drugs may develop impulse control problems
    Over time, half of the people taking certain drugs for Parkinson's disease may develop impulse control disorders such as compulsive gambling, shopping or eating, according to a new study. ... read more
    Source: Science DailyPublished on 2018-06-20
  • What does it mean if you have shaky hands?
    Shaky hands can interfere with everyday activities, and the tremors vary in severity. Neurological conditions, movement disorders, and issues such as anxiety or withdrawal may be responsible for the tremors, and a wide range of treatments are available. Learn more about shaky hands and types of tremor here. ... read more
    Source: Medical News DailyPublished on 2018-06-20
  • World’s first intra-operative MRI-guided robot for bilateral stereotactic neurosurgery
    (The University of Hong Kong) A HKU Mechanical Engineering team led by Dr. Kwok Ka-wai recently designed the first neurosurgical robotic system capable of performing bilateral stereotactic neurosurgery inside a magnetic resonance imaging ('MRI') scanner. The team also conducted pre-clinical validation of the system with CUHK neurosurgeons, Dr Danny Chan ... read more
    Source: Eureka AlertPublished on 2018-06-19
  • Is Radotinib ABL to beat Nilotinib?
      At the Society for Neuroscience annual meeting in 2015, the results of a small phase I clinical trial were presented and the Parkinson’s community got really excited by what they saw. The study had investigated the use of a cancer drug called ‘Nilotinib’ (also known as Tasigna) on Parkinson’s ... read more
    Source: The Science of Parkinson’s diseasePublished on 2018-06-17By Simon
  • Gender Differences in Parkinson’s Disease
    Not only do women appear to be better protected against the effects of Parkinson's disease, a new study reveals a gender specific pathology exists in women with the disease as soon as the symptoms appear. ... read more
    Source: Neuro Science NewsPublished on 2018-06-16By Neuroscience News
  • Blessed are the suppressed
    Recently a study was published in which the researchers had used a large dataset from the the United States Medicare system. The dataset held medical prescriptions for beneficiaries aged 60–90 years. In their analysis, the researchers found that several diagnoses commonly treated with immunosuppressant medications were inversely associated with ... read more
    Source: The Science of Parkinson’s diseasePublished on 2018-06-16By Simon
  • Is There a Link Between Diabetes and Parkinson’s?
    According to researchers, people with type 2 diabetes have a higher risk of being diagnosed with Parkinson's disease later in life. The study reports the risk may be higher for younger people and those with complications related to diabetes. ... read more
    Source: Neuro Science NewsPublished on 2018-06-15By Neuroscience News
  • Parkinson’s: Could this ‘missing link’ be a cause?
    Cell defects and genes have been separately identified in Parkinson's disease. Now, scientists suggest a faulty cell mechanism is the missing link. ... read more
    Source: Medical News DailyPublished on 2018-06-15
  • What do you do with a problem like Exenatide?
        At 23:30 on the 3rd August 2017, the results of a phase II clinical trial investigating the use of a Glucagon-like peptide-1 receptor (GLP-1R) agonist called Exenatide (Bydureon) in Parkinson’s were published the Lancet journal website. The findings of the study were very interesting. And ... read more
    Source: The Science of Parkinson’s diseasePublished on 2018-06-13By Simon
  • Hypertension May Cause Dementia
    An MRI study reveals neuroimaging can detect early signs of neurological damage in people with hypertension before symptoms of dementia occur. ... read more
    Source: Neuro Science NewsPublished on 2018-06-13By Neuroscience News
  • Scientists unravel molecular mechanisms of Parkinson’s disease
    Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease. ... read more
    Source: Science DailyPublished on 2018-06-12
  • Molecular Mechanisms of Parkinson’s Disease Unraveled
    In Parkinson's disease, alpha synuclein clumps move to and damage mitochondrial proteins, making them less efficient and causing the mitochondrial to burst, leaking out chemicals that tell the cells to die, researchers say. ... read more
    Source: Neuro Science NewsPublished on 2018-06-12By Neuroscience News
  • Is Parkinson’s linked to bacteriophages?
    Although Parkinson's is a neurological condition, new research finds that levels of bacteria and bacteriophages in the gut might also be important. ... read more
    Source: Medical News DailyPublished on 2018-06-12
  • Scientists unravel molecular mechanisms of Parkinson’s disease
    (The Francis Crick Institute) Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease. ... read more
    Source: Eureka AlertPublished on 2018-06-12
  • Don’t get mad! Get NAD!
    Recently researchers have provided very interesting evidence that a form of vitamin B3, called Nicotinamide Riboside, may have beneficial effects for Parkinson’s. Their data suggests that nicotinamide riboside was able to rescue problems in mitochondria – the power stations of cells – in both fly and human cell-based models ... read more
    Source: The Science of Parkinson’s diseasePublished on 2018-06-11By Simon
  • This ‘light-activated’ drug could treat Parkinson’s
    A drug activated in the brain using light delivered by implanted optical fiber improved motor function and reduced Parkinson's symptoms in mice. ... read more
    Source: Medical News DailyPublished on 2018-06-11
  • Bacteriophages: Are they an overlooked driver of Parkinson’s disease?
    (American Society for Microbiology) In the first study of its kind, researchers from the New York-based Human Microbiology Institute have discovered the role certain bacteriophages may play in the onset of Parkinson's disease (PD). The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology, ... read more
    Source: Eureka AlertPublished on 2018-06-10
  • Researchers Reverse Cognitive Impairments in Mice with Dementia
    Researchers report tau pathology can be reversed in Alzheimer's patients with the help of a drug. Their study reveals reversing tau pathology in mouse models of dementia resulted in a reversal of cognitive deficits in spatial learning. ... read more
    Source: Neuro Science NewsPublished on 2018-06-09By Neuroscience News
  • Researchers Reverse Cognitive Impairments in Mice with Dementia
    Researchers report tau pathology can be reversed in Alzheimer's patients with the help of a drug. Their study reveals reversing tau pathology in mouse models of dementia resulted in a reversal of cognitive deficits in spatial learning. ... read more
    Source: Neuro Science NewsPublished on 2018-06-09By Neuroscience News
  • Parkinson’s: Vitamin B-3 may stop brain cell death
    A Parkinson's study using human cells and a fly model found that a form of vitamin B-3 prevented the death of brain cells by preserving their mitochondria. ... read more
    Source: Medical News DailyPublished on 2018-06-08
  • Sleep problems in Parkinson’s disease: Can we fix them?
    Researchers have uncovered why people with a hereditary form of Parkinson's disease suffer from sleep disturbances. The molecular mechanisms uncovered in fruit flies and human stem cells also point to candidate targets for the development of new treatments. ... read more
    Source: Science DailyPublished on 2018-06-07
  • Sleep problems in Parkinson’s disease: Can we fix them?
    (VIB (the Flanders Institute for Biotechnology)) A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson's disease suffer from sleep disturbances. The molecular mechanisms uncovered in fruit flies and human stem cells also point to candidate targets for the development of ... read more
    Source: Eureka AlertPublished on 2018-06-07
  • A Typical Communication Pattern of People with Alzheimer’s
    Researchers provide a statistical analysis of 'saving appearance responses' in patients with dementia. The study reveals the SAR responses are particularly common in those with Alzheimer's disease. ... read more
    Source: Neuro Science NewsPublished on 2018-06-06By Neuroscience News
1 2 3 43